Ramachandra Sumant made one open market purchase of Lyell Immunopharma ($LYEL) shares in the last year, totaling $115 thousand. His most recent buy was on March 21, 2025. This ranks him 2018th out of nearly 5,000 insiders by purchase amount, well below the average of $1.5 million across 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | Lyell Immunopharma, Inc. | $LYEL | Ramachandra Sumant | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 295,228,868 | 9999.99% | 0.04% |
| March 21, 2025 | Lyell Immunopharma, Inc. | $LYEL | Ramachandra Sumant | Not found | P | Common Stock | 200000 | $0.58 | 200,000.0000 | 295,228,868 | 9999.99% | 0.07% |
| Oct. 31, 2024 | Lyell Immunopharma, Inc. | $LYEL | Ramachandra Sumant | Not found | A | Option (right to buy) | 260000 | $0.00 | 260,000.0000 | 0 | 9999.99% | 0.00% |